Login
$TRLV
$10.44 +$0.11 (1.06%) After hours

$TRLV SEC Filings

Filed On Filing
05 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Tallahassee, FL – November 5, 2026 – Trulieve Cannabis Corp. (NYSE: TRLV) (“Trulieve” or “the Company”), a leading and top-performing medical cannabis company in the U.S., today announced its results for the quarter ended September 30, 2...

24 Aug 2026 S-8 POS
24 Aug 2026 POSASR
11 Aug 2026 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more

PLAN OF ARRANGEMENT PLAN OF ARRANGEMENT UNDER SECTION 288 OF THE BUSINESS CORPORATIONS ACT (BRITISH COLUMBIA) ARTICLE I INTERPRETATION 1.1 Definitions In this Plan of Arrangement, unless there is something in the subject matter or contex...

07 Aug 2026 10-Q
07 Aug 2026 8-K: Completion of Acquisition or Disposition of Assets; Regulation FD Disclosure

Tallahassee, FL – August 7, 2026 – Trulieve Cannabis Corp. (NYSE: TRLV) (“Trulieve” or “the Company”), a leading and top-performing medical cannabis company in the U.S., today announced its results for the quarter ended June 30, 2026. Re...

05 Aug 2026 8-K: Submission of Matters to a Vote of Security Holders

On August 5, 2026, Trulieve Cannabis Corp. (the "Company") held a special meeting of shareholders (the "Special Meeting"). The following are the voting results for the proposals considered and voted upon at the Special Meeting, each of w...

08 Jul 2026 SCHEDULE 13G
02 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation
26 Jun 2026 Form 4: Rivers Kim A., Director

Sold 136,811 shares ($1.2M)

25 Jun 2026 Form 4: Rivers Kim A., Director

Sold 380,000 shares ($3.22M) · Sold 400,000 shares ($3.27M) · Sold 300,000 shares ($2.45M)

25 Jun 2026 DEF 14A
25 Jun 2026 DEFA14A
22 Jun 2026 Form 4: Rivers Kim A., Director

Sold 137,535 shares ($1.29M) · Sold 139,846 shares ($1.32M) · Sold 204,815 shares ($1.92M)

17 Jun 2026 144
12 Jun 2026 PRE 14A
12 Jun 2026 8-K: Departure/Election of Directors or Officers; Compensation

On June 11, 2026 (the “Termination Date”), the Company and Jason Pernell mutually agreed that Mr. Pernell shall terminate his employment his position of President of Trulieve Cannabis Corp. (the “Company”) effective immediately. In conne...

11 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

The following are the voting results for the proposals considered and voted upon at the Meeting, each of which is described in detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April ...

09 Jun 2026 NYSE CERTIFICATION

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support